| Product Name | LL-37 Powder |
|
CAS No. |
597562-32-8 |
|
Other Names |
LL-37 Powder |
|
MF |
C205H341N61O52 |
|
Place of Origin |
China |
|
Purity |
99% |
|
Appearance |
White powder |
|
Usage |
Cosmetic Raw Materials, Detergent Raw Materials, Hair Care Chemicals, Oral Care Chemicals |
|
Apperance |
White powder |
|
Grade |
Comestic Grade |
|
Shelf life |
2 Years |
Products Description
What is LL-37 Powder?
LL-37 is the only human cathelicidin antimicrobial peptide, derived from the cleavage of the precursor protein hCAP-18. It exhibits multifunctional biological activities beyond antimicrobial action, playing critical roles in host defense, tissue repair, and immune regulation. Below is a detailed breakdown of its efficacy and applications:

Product COA
Certificate Of Analysis
|
Product Name |
LL-37 Powder |
CAS No. |
597562-32-8 |
|
Molecular Formula |
C205H341N61O52 |
Molecular Weight |
4492.27854 |
|
Batch No. |
XR23110801-6 |
Date of Mfg |
Dec 27,2025 |
|
Reference Standard |
Enterprise Standard |
Retest Date |
Dec 26,2028 |
|
Storage |
In an airtight container,protected from light,at a temperature of 2℃ to 8℃. |
||
|
TEST |
SPECIFICATION |
RESULT |
|
|
Appearance |
White or almost white fluffy powder |
Conform |
|
|
Solubility |
Soluble in water |
Conform |
|
|
Water Content (Karl Fischer) |
≤ 8.0% |
2.20% |
|
|
Sodium ion |
≤ 5.0% |
1.65% |
|
|
Acetic Acid |
≤ 0. 1% |
0.07% |
|
|
Trifluoroacetic Acid |
≤ 0.5% |
Not Detected |
|
|
Peptide Purity (By HPLC) |
≥ 98.0% |
99.32% |
|
|
Related Substance (By HPLC) |
Total Impurities(%) ≤ 2.0% |
0.68% |
|
|
Largest Single Impurity(%) ≤ 1.0% |
0.31% |
||
|
Bacterial Endotoxins |
≤10EU/mg |
Conform |
|
|
Assay |
≥ 90.0% |
94.42% |
|
|
Residual Solvents |
NMT 0.041% |
0.03% |
|
|
Conclusion |
This batch of product conforms with enterprise standard and qualified. |
||
Broad-Spectrum Antimicrobial Activity
LL-37 exerts potent microbicidal effects through multiple mechanisms:
Membrane Disruption: Its amphipathic α-helical structure inserts into microbial cell membranes, forming pores that cause leakage of intracellular contents and cell lysis.
Intracellular Targeting: Inhibits bacterial DNA/RNA synthesis, interferes with protein folding, and disrupts viral replication cycles (e.g., HIV-1, influenza, COVID-19).
Resistance Overcoming: Effective against multidrug-resistant pathogens including MRSA, carbapenem-resistant Enterobacteriaceae (CRE), and ESKAPE bacteria, making it a promising candidate for combating antibiotic resistance.
Immunomodulatory and Anti-Inflammatory Functions
Immune Cell Activation: Recruits and activates neutrophils, macrophages, and dendritic cells via formyl peptide receptor-like 1 (FPRL1), enhancing phagocytosis and cytokine production.
Inflammation Regulation: Modulates the release of pro-inflammatory cytokines (TNF-α, IL-6) and chemokines, reducing excessive tissue damage while maintaining host defense.
Barrier Integrity: Promotes epithelial cell proliferation and tight junction formation, reinforcing mucosal and cutaneous barriers against pathogens.
Clinical and Therapeutic Applications
Antimicrobial Therapy
Skin and Soft Tissue Infections: Topical formulations (ointments, gels) treat acne, impetigo, and diabetic foot ulcers by targeting local pathogens and accelerating healing.
Respiratory Infections: Inhaled LL-37 shows potential in managing pneumonia, COPD, and cystic fibrosis by reducing bacterial colonization and mucus viscosity.
Oral Care: Mouthwashes and lozenges combat periodontitis, gingivitis, and oral candidiasis by eliminating pathogenic biofilms.
Wound Healing and Tissue Regeneration
Chronic Wound Management: Stimulates keratinocyte migration, angiogenesis, and collagen deposition, promoting closure of non-healing wounds (e.g., venous ulcers, pressure sores).
Ophthalmology: Eye drops containing LL-37 treat dry eye syndrome, corneal ulcers, and conjunctivitis by reducing inflammation and enhancing epithelial repair.
Inflammatory and Autoimmune Disorders
Dermatological Conditions: Investigated for psoriasis and atopic dermatitis due to its ability to balance immune responses and restore skin barrier function.
Gastrointestinal Diseases: Shows promise in inflammatory bowel disease (IBD) by reducing intestinal inflammation and maintaining mucosal integrity.
Anticancer Therapy
Direct Cytotoxicity: Induces apoptosis in cancer cells (gastric, colorectal, hematological malignancies) through membrane permeabilization and mitochondrial dysfunction.
Adjuvant Therapy: Enhances the efficacy of chemotherapy and immunotherapy by modulating tumor microenvironment and reducing treatment-induced mucositis.
Research and Biotechnological Applications
Antibiotic Development: Serves as a template for designing novel antimicrobial peptides with improved stability and reduced cytotoxicity.
Vaccine Adjuvant: Boosts antigen-specific immune responses by activating dendritic cells, enhancing vaccine efficacy against infectious diseases and cancer.
Biomedical Materials: Coated onto medical devices (catheters, implants) to prevent biofilm formation and reduce surgical site infections.
Safety and Administration
Biocompatibility: Naturally produced in humans, LL-37 has low immunogenicity and is degraded into harmless amino acids by proteases.
Delivery Routes: Administered topically, orally, inhaled, or via injection, depending on the target condition.
Side Effects: Mild local irritation may occur with high-dose topical application; systemic toxicity is rare due to rapid degradation.
| Type | Product Name | Speafication | Standard |
| Female hormones | Progesterone | 57-83-0 | USP39 |
| Estriol | 50-27-1 | USP41 | |
| Estrogen | 56-53-1 | USP41 | |
| Estradiol benzoate | 50-50-0 | USP | |
| β-ESTRADIOL | 50-28-2 | USP39 | |
| Ethynyl estradiol | 57-63-6 | USP | |
| Megestrol acetate | 595-33-5 | USP39 | |
| 17a-Hydroxyprogesterone caproate | 630-56-8 | USP | |
| Oestradiol 17-heptanoate | 4956-37-0 | USP | |
| Depofemin | 313-06-4 | USP37 | |
| Pregnenolone | 145-13-1 | USP | |
| Levonorgestrel | 797-63-7 | USP |





Hot Products








FAQ
Q1. What is the ordering process for the product?
Answer: Please tell us the specific product and quantity you need, provide your shipping information, select the payment method, and we will arrange the shipment for you as soon as possible after the payment is successful.
Q2. Do you have a minimum order quality?
Answer: Yes, our minimum order quality is one boxes, and of course you can contact us if you need less.
Q3. What is the price of the product?
Answer: Our price changes with the international market. An updated price list will be provided when you contact us.
Q4. How to make the payment?
Answer: We can accept Western Union, Bitcoin, Ali baba, Credit Card, Bank Transfer and other payment methods available.
Q5. When will you deliver the goods?
Answer: After receiving the remittance, we will arrange the delivery for you as soon as possible. The tracking number will be provided to you within 3 days.
Q6. How will you deliver the goods?
Answer: We have professional express forwarder, strong cooperate with DHL, UPS, USPS, FedEx, EMS, China Air Post.
Q7. When will we receive the goods?
Answer: We will send by DHL/FEDEX/UPS/USPS express, usually it takes about 7-15 days to reach you.
Hot Tags: glow/klow/ghk-cu/ll-37/melatonin peptides, China glow/klow/ghk-cu/ll-37/melatonin peptides manufacturers, suppliers, factory, Pramoxine HCl for Skin Irritation Soothing, Ivermectin for Pet Parasite Control, Fenbendazole for Animal Worming, Zinc Bacitracin for Antiseptic Treatment, Povidone Iodine Chemical, Sulforaphane for Antioxidant Support











